femtos pEGASUS (HPC) Stent System
- Registration number
- DE0510055
- Model name
- pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System; pEGASUS Stent System
- Model identifier
- PEGASUS-350-15; pEGASUS-350-15-HPC; PEGASUS-350-20; pEGASUS-350-20-HPC; PEGASUS-350-25; pEGASUS-350-25-HPC; PEGASUS-350-30; pEGASUS-350-30-HPC; PEGASUS-450-15; pEGASUS-450-15-HPC; PEGASUS-450-20; pEGASUS-450-20-HPC; PEGASUS-450-25; pEGASUS-450-25-HPC; PEGASUS-450-30; pEGASUS-450-30-HPC
- Registration date
- November 19, 2024
- Source update date
- December 04, 2025
- Risk class
- Class D
- Product owner
- femtos GmbH
- Registrant / registration holder
- ANDAMAN MEDICAL PTE. LTD.
The pEGASUS (HPC) Stent System is a self-expanding, tubular vascular implant and allows the endovascular reconstruction of diseased arteries in the cervical and intracranial course. Indications: The self-expanding, tubular vascular implant pEGASUS (HPC) Stent System is used for the endovascular treatment of the following vascular diseases • saccular and fusiform aneurysms in combination with coils, and • atherosclerotic vascular stenosis of intracranial arteries (ICA), middle cerebral artery (MCA), basilar artery (BA), and vertebral artery (VA).
- Product owner address
- Universitätsstr. 136,, 44799 Bochum, Germany, Germany
- Registrant address
- 300 TAMPINES AVENUE 5, #09-02, INCOME AT TAMPINES JUNCTION, Singapore 529653
This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.